SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.2960A>GD987GLikely PathogenicUncertain 1-4.782Likely Benign0.849Likely PathogenicAmbiguous0.234Likely Benign-2.79Deleterious0.943Possibly Damaging0.808Possibly Damaging2.45Pathogenic0.07Tolerated4.3221-13.1-58.04
c.2650C>TR884WLikely BenignUncertain 16-33443202-C-T53.10e-6-3.785Likely Benign0.332Likely BenignLikely Benign0.151Likely Benign0.26Neutral0.995Probably Damaging0.812Possibly Damaging2.56Benign0.05Affected4.324-323.630.03
c.2860C>TP954SLikely BenignLikely Benign 16-33443412-C-T16.20e-7-3.525Likely Benign0.062Likely BenignLikely Benign0.143Likely Benign-0.25Neutral0.954Possibly Damaging0.812Possibly Damaging2.87Benign1.00Tolerated3.7751-10.8-10.04
c.745G>AA249T
(3D Viewer)
Likely BenignPHUncertain 1-3.564Likely Benign0.805Likely PathogenicAmbiguous0.487Likely Benign1.50Ambiguous0.61.39Ambiguous1.45Ambiguous0.30Likely Benign-0.96Neutral0.990Probably Damaging0.815Possibly Damaging5.65Benign0.40Tolerated3.391510-2.530.03214.5-43.30.00.00.50.2XPotentially BenignThe methyl group of Ala249, located on the surface of an α helix (res. Ala236-Val250) facing an anti-parallel β sheet strand (res. Ile205-Val209), packs against nearby hydrophobic residues such as Leu200, Leu246, and Val250. In the variant simulations, the hydroxyl group of Thr249, which is not suitable for hydrophobic packing, forms a stable hydrogen bond with the backbone carbonyl of Asn245 in the same helix. Although this interaction could theoretically weaken the structural integrity of the α helix, this destabilizing effect is not observed in the variant simulations.
c.1586T>CI529T
(3D Viewer)
Likely BenignGAPUncertain 1-0.539Likely Benign0.336Likely BenignLikely Benign0.343Likely Benign0.22Likely Benign0.20.16Likely Benign0.19Likely Benign0.17Likely Benign0.24Neutral0.872Possibly Damaging0.820Possibly Damaging-1.23Pathogenic0.55Tolerated3.37350-1-5.2-12.05207.229.80.20.00.20.1XPotentially BenignIle529 is located on an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560). In the WT simulations, the sec-butyl side chain of Ile529 faces the membrane interface and shows no specific interactions. In the variant simulations, the hydroxyl group of Thr529 forms a hydrogen bond with the carboxylate side chain of Asp527, but no negative structural changes are observed. However, due to its location near the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.
c.2206C>TR736CConflicting 36-33441671-C-T84.96e-6-7.113In-Between0.120Likely BenignLikely Benign0.190Likely Benign-2.06Neutral0.999Probably Damaging0.825Possibly Damaging2.48Pathogenic0.00Affected4.073-4-37.0-53.05
c.3511_3512delinsTGA1171CLikely BenignCoiled-coilUncertain 1-5.363Likely Benign0.496AmbiguousLikely Benign-1.16Neutral0.978Probably Damaging0.825Possibly Damaging5.32Benign0.02Affected4.324-200.732.06
c.1925A>CK642T
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-12.823Likely Pathogenic0.948Likely PathogenicAmbiguous0.484Likely Benign0.53Ambiguous0.10.30Likely Benign0.42Likely Benign0.28Likely Benign-5.88Deleterious0.872Possibly Damaging0.839Possibly Damaging2.86Benign0.00Affected3.37310-13.2-27.07213.5-8.7-0.30.40.30.2XUncertainThe amino side chain of Lys642, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the shorter side chain of Thr642 forms hydrogen bonds with Glu643 and Thr640 on the same α helix.Regardless, Lys642 is positioned directly at the GAP-Ras interface, and in the SynGAP-Ras WT simulations, its amino side chain forms salt bridges with the carboxylate groups of Ras residues Asp33 and Asp38. The shorter Thr642 is more likely to prefer hydrogen bonding with Glu643 and Thr640 on the same α helix, even in the Ras complex. Thus, the effect of the residue swap on the complex formation with the GTPase cannot be explored using solvent-only simulations.
c.3251C>AP1084HLikely BenignUncertain 16-33443803-C-A16.31e-7-4.125Likely Benign0.323Likely BenignLikely Benign0.134Likely Benign-3.16Deleterious0.997Probably Damaging0.840Possibly Damaging3.96Benign0.00Affected3.775-20-1.640.02
c.1370G>AS457NLikely PathogenicGAPUncertain 1-10.221Likely Pathogenic0.949Likely PathogenicAmbiguous0.241Likely Benign0.19Likely Benign0.0-0.22Likely Benign-0.02Likely Benign0.67Ambiguous-2.76Deleterious0.940Possibly Damaging0.843Possibly Damaging3.28Benign0.06Tolerated11-2.727.03
c.1136C>GS379W
(3D Viewer)
C2Uncertain 16-33438041-C-G-8.898Likely Pathogenic0.388AmbiguousLikely Benign0.520Likely Pathogenic4.32Destabilizing3.43.56Destabilizing3.94Destabilizing0.16Likely Benign-1.02Neutral0.998Probably Damaging0.844Possibly Damaging3.82Benign0.01Affected4.3211-2-3-0.199.14271.3-75.71.41.00.60.5UncertainSer379 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like tryptophan are rarely tolerated. Although no major negative structural effects are observed in the variant simulations, Trp379 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn
c.2060G>AR687Q
(3D Viewer)
Likely PathogenicGAPLikely Benign 1-10.002Likely Pathogenic0.575Likely PathogenicLikely Benign0.401Likely Benign0.92Ambiguous0.1-0.37Likely Benign0.28Likely Benign1.55Destabilizing-3.37Deleterious1.000Probably Damaging0.844Possibly Damaging3.91Benign0.03Affected3.4217111.0-28.06
c.3056G>AR1019HLikely BenignConflicting 26-33443608-G-A674.15e-5-4.610Likely Benign0.258Likely BenignLikely Benign0.122Likely Benign-1.95Neutral0.995Probably Damaging0.845Possibly Damaging2.39Pathogenic0.01Affected3.775201.3-19.05
c.2291A>GN764SLikely BenignBenign 1-3.149Likely Benign0.159Likely BenignLikely Benign0.058Likely Benign-0.84Neutral0.992Probably Damaging0.846Possibly Damaging2.65Benign0.61Tolerated3.646112.7-27.03
c.2573G>AS858NLikely BenignUncertain 16-33443125-G-A21.24e-6-4.311Likely Benign0.121Likely BenignLikely Benign0.107Likely Benign-0.67Neutral0.448Benign0.846Possibly Damaging4.13Benign0.02Affected3.77511-2.727.03
c.1760G>CR587T
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.697Likely Pathogenic0.784Likely PathogenicLikely Benign0.603Likely Pathogenic1.14Ambiguous0.20.74Ambiguous0.94Ambiguous0.98Ambiguous-4.71Deleterious0.998Probably Damaging0.847Possibly Damaging-1.19Pathogenic0.08Tolerated3.3735-1-13.8-55.08227.287.40.00.00.50.1XPotentially PathogenicThe guanidinium group of Arg587, located on an α helix (res. Glu582-Met603), is constantly rotating and breaking/forming multiple hydrogen bonds and/or salt bridges at the surface intersection of α helices in the WT simulations. The positively charged Arg587 side chain can form a salt bridge with either the carboxylate group of Asp583 or Asp586 in the same helix, or with Glu480 on the opposing short helical loop structure (res. Glu480-Leu482).Importantly, the Arg587 side chain also hydrogen bonds with the backbone carbonyl groups of Ala634 and Asn635, as well as the carboxamide group of Asn635 at the end of another α helix (res. Asp616-Phe636). However, in the variant simulations, the neutral hydroxyl group of the Thr587 side chain is unable to form these salt bridges. Due to its smaller size, it also does not form the hydrogen bonds that the Arg587 side chain could. Instead, the hydroxyl group of Thr587 hydrogen bonds with the backbone carbonyl group of Asp583, which could weaken the integrity of the α helix, although this is not observed in the simulations.Overall, the residue swap could weaken the tertiary structure assembly and negatively affect the overall protein folding process.
c.508C>TR170WLikely PathogenicUncertain 2-11.660Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.241Likely Benign-4.28Deleterious0.999Probably Damaging0.849Possibly Damaging3.84Benign0.00Affected3.7442-33.630.03
c.3196C>TP1066SLikely BenignLikely Pathogenic 1-4.746Likely Benign0.070Likely BenignLikely Benign0.145Likely Benign-2.47Neutral0.972Probably Damaging0.850Possibly Damaging2.74Benign0.00Affected4.3221-10.8-10.04
c.1300G>AV434I
(3D Viewer)
Likely BenignGAPUncertain 16-33438205-G-A16.19e-7-6.999Likely Benign0.129Likely BenignLikely Benign0.192Likely Benign-0.04Likely Benign0.00.22Likely Benign0.09Likely Benign0.31Likely Benign-0.82Neutral0.947Possibly Damaging0.851Possibly Damaging3.53Benign0.18Tolerated3.3729430.314.03246.7-27.70.00.00.10.0XPotentially BenignThe iso-propyl side chain of Val434, located at the end of an α helix (res. Met414-Glu436), packs against hydrophobic residues in an interhelix space (e.g., Met430, Ala707, Leu711). In the variant simulations, the sec-butyl group of Ile434 is able to form the same hydrophobic interactions. Accordingly, the residue swap does not negatively affect the protein structure based on the simulations.
c.1339G>CV447L
(3D Viewer)
Likely BenignGAPUncertain 1-5.136Likely Benign0.491AmbiguousLikely Benign0.180Likely Benign-1.13Ambiguous0.10.54Ambiguous-0.30Likely Benign0.03Likely Benign-0.29Neutral0.947Possibly Damaging0.851Possibly Damaging3.61Benign0.90Tolerated3.373212-0.414.03
c.1354G>AV452I
(3D Viewer)
GAPUncertain 1-8.985Likely Pathogenic0.361AmbiguousLikely Benign0.218Likely Benign-0.08Likely Benign0.10.51Ambiguous0.22Likely Benign0.25Likely Benign-0.99Neutral0.947Possibly Damaging0.851Possibly Damaging3.26Benign0.05Affected430.314.03
c.1771G>CA591P
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.479Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.404Likely Benign3.78Destabilizing0.37.29Destabilizing5.54Destabilizing1.45Destabilizing-4.41Deleterious0.995Probably Damaging0.853Possibly Damaging3.35Benign0.01Affected3.37351-1-3.426.04191.5-10.10.20.10.40.1XPotentially PathogenicThe methyl group of the Ala591 side chain, located in the middle of an α helix (res. Glu582-Met603), packs against hydrophobic residues (e.g., Ile483, Phe484) of an opposing partially helical loop (res. Phe476-Asn487).In the variant simulations, Pro591 lacks a free backbone amide group and, therefore, cannot form a hydrogen bond with the backbone carbonyl of Arg587 as Ala591 does in the WT. This notably weakens the α helix integrity and compromises the continuity of the helix. In reality, the effect on the structure during protein folding could be more severe.
c.3979C>TP1327SLikely BenignUncertain 16-33451853-C-T-4.744Likely Benign0.131Likely BenignLikely Benign0.092Likely Benign0.28Neutral0.980Probably Damaging0.857Possibly Damaging4.25Benign0.71Tolerated3.7751-10.8-10.04
c.1231A>GI411V
(3D Viewer)
Likely BenignGAPLikely Benign 1-6.290Likely Benign0.385AmbiguousLikely Benign0.212Likely Benign0.74Ambiguous0.00.82Ambiguous0.78Ambiguous0.99Ambiguous-0.86Neutral0.935Possibly Damaging0.858Possibly Damaging3.90Benign0.27Tolerated3.382843-0.3-14.03233.328.2-0.20.0-0.20.0XPotentially BenignThe sec-butyl side chain of Ile411, located in the hydrophobic space between an anti-parallel β sheet strand (res. Pro398-Ile411) and an α helix (res. Asp684-Gln702), packs against multiple residues (e.g., Met409, Arg259). In the variant simulations, the side chain of Val411 is able to favorably fill the same hydrophobic niche despite its slightly smaller size. In short, the residue swap has no apparent negative effect on the structure based on the simulations.
c.1678G>AV560M
(3D Viewer)
GAPUncertain 26-33440730-G-A159.50e-6-9.598Likely Pathogenic0.517AmbiguousLikely Benign0.520Likely Pathogenic-0.33Likely Benign0.10.88Ambiguous0.28Likely Benign0.72Ambiguous-2.42Neutral0.999Probably Damaging0.863Possibly Damaging-1.25Pathogenic0.14Tolerated3.373521-2.332.06234.9-52.60.00.0-0.10.1XPotentially BenignVal560 is located on the surface at the end of an α-helix (res. Ala533-Val560). The iso-propyl group of Val560 favorably packs against Asp508 of the opposing α-helix (res. Gln503-Glu519). However, in the variant simulations, the bulkier thioether side chain of Met560 does not form equally favorable inter-helix interactions. Regardless, no negative structural effects are observed during the simulations.
c.2324G>AR775QLikely BenignConflicting 36-33442482-G-A111.41e-5-4.476Likely Benign0.229Likely BenignLikely Benign0.085Likely Benign-0.63Neutral0.969Probably Damaging0.863Possibly Damaging4.17Benign0.16Tolerated3.646111.0-28.0610.1016/j.ajhg.2020.11.011
c.2623G>AA875TLikely BenignUncertain 16-33443175-G-A16.20e-7-3.793Likely Benign0.179Likely BenignLikely Benign0.110Likely Benign-1.56Neutral0.972Probably Damaging0.864Possibly Damaging2.72Benign0.26Tolerated3.77501-2.530.03
c.227C>GS76CLikely BenignUncertain 16-33425835-C-G21.24e-6-5.408Likely Benign0.100Likely BenignLikely Benign0.076Likely Benign-1.78Neutral0.992Probably Damaging0.869Possibly Damaging3.71Benign0.00Affected4.3210-13.316.06
c.2115G>CK705N
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.183Likely Benign0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.4710100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2282G>AR761QLikely BenignUncertain 16-33441747-G-A116.81e-6-4.187Likely Benign0.202Likely BenignLikely Benign0.191Likely Benign-0.63Neutral0.996Probably Damaging0.878Possibly Damaging2.75Benign0.40Tolerated3.995111.0-28.06
c.743G>CR248P
(3D Viewer)
Likely PathogenicPHLikely Pathogenic 1-10.751Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.848Likely Pathogenic3.09Destabilizing0.68.87Destabilizing5.98Destabilizing1.21Destabilizing-5.97Deleterious0.998Probably Damaging0.878Possibly Damaging5.64Benign0.00Affected3.41140-22.9-59.07223.8126.60.00.0-0.20.1XXPotentially PathogenicThe guanidinium group of Arg248, located on an α helix (residues Ala236-Val250), forms two very stable salt bridges with Asp255 (from a short α helical section, res. Lys254-Asn256) and Glu244 (from a nearby loop) in the WT simulations. In the variant simulations, the pyrrolidine side chain of Pro248 cannot form any salt bridges, which could negatively affect the tertiary structure assembly of the PH domain. Additionally, Pro248 lacks a free amide group needed for hydrogen bonding with the backbone carbonyl group of Asn245, disrupting the continuity of the α helix.
c.169C>TL57FLikely BenignUncertain 2-5.096Likely Benign0.459AmbiguousLikely Benign0.051Likely Benign-0.78Neutral0.824Possibly Damaging0.879Possibly Damaging3.96Benign0.00Affected4.32120-1.034.02
c.303C>AH101QLikely BenignUncertain 16-33432168-C-A16.20e-7-2.827Likely Benign0.124Likely BenignLikely Benign0.147Likely Benign-0.37Neutral0.824Possibly Damaging0.880Possibly Damaging4.24Benign0.00Affected4.32130-0.3-9.01
c.3055C>TR1019CLikely PathogenicConflicting 26-33443607-C-T106.19e-6-7.386In-Between0.646Likely PathogenicLikely Benign0.168Likely Benign-4.00Deleterious0.999Probably Damaging0.880Possibly Damaging2.36Pathogenic0.00Affected3.775-4-37.0-53.0510.1016/j.ajhg.2020.11.011
c.2219G>AR740QLikely BenignUncertain 16-33441684-G-A42.48e-6-5.195Likely Benign0.078Likely BenignLikely Benign0.102Likely Benign-0.67Neutral0.999Probably Damaging0.881Possibly Damaging2.60Benign0.08Tolerated4.322111.0-28.06
c.1404G>AM468I
(3D Viewer)
Likely PathogenicGAPUncertain 16-33438436-G-A16.20e-7-8.583Likely Pathogenic0.907Likely PathogenicAmbiguous0.508Likely Pathogenic2.53Destabilizing0.21.89Ambiguous2.21Destabilizing0.37Likely Benign-1.06Neutral0.748Possibly Damaging0.886Possibly Damaging-1.10Pathogenic0.07Tolerated3.3731122.6-18.03
c.1172G>TG391V
(3D Viewer)
Likely BenignC2Likely Benign 16-33438077-G-T31.86e-6-6.642Likely Benign0.133Likely BenignLikely Benign0.595Likely Pathogenic4.23Destabilizing1.34.81Destabilizing4.52Destabilizing-0.11Likely Benign-0.98Neutral0.994Probably Damaging0.887Possibly Damaging1.32Pathogenic0.10Tolerated3.698-1-34.642.08228.6-69.00.00.8-0.50.3UncertainGly387 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. This loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like valine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Val391 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.2105A>GQ702R
(3D Viewer)
GAPUncertain 1-7.894In-Between0.348AmbiguousLikely Benign0.294Likely Benign-0.31Likely Benign0.10.63Ambiguous0.16Likely Benign0.13Likely Benign-3.14Deleterious0.909Possibly Damaging0.889Possibly Damaging3.43Benign0.02Affected3.471011-1.028.06270.3-52.90.00.00.00.1XPotentially PathogenicThe carboxamide side chain of Gln702 is located at the end and outer surface of an α-helix (res. Leu685-Gln702), where it does not directly form hydrogen bonds with any residues in the WT simulations. In the variant simulations, the positively charged guanidinium group of Arg702 forms a salt bridge with the negatively charged carboxylate group of Glu698 on the same helix and/or hydrogen bonds with the backbone carbonyl group of Ala438 on an opposite α-helix (res. Tyr428-Glu436). Consequently, the residue swap could strengthen the tertiary structure assembly, which could have either positive or negative effects on its function.
c.2195G>CR732TUncertain 1-8.545Likely Pathogenic0.434AmbiguousLikely Benign0.075Likely Benign-1.96Neutral0.999Probably Damaging0.892Possibly Damaging2.59Benign0.12Tolerated3.597-1-13.8-55.08
c.892C>TP298S
(3D Viewer)
Likely BenignC2Benign 16-33437797-C-T53.10e-6-6.342Likely Benign0.144Likely BenignLikely Benign0.189Likely Benign1.38Ambiguous0.21.41Ambiguous1.40Ambiguous0.58Ambiguous-1.20Neutral0.991Probably Damaging0.898Possibly Damaging2.03Pathogenic0.85Tolerated3.3920-110.8-10.04
c.2561G>AR854HLikely BenignUncertain 16-33443113-G-A42.48e-6-3.686Likely Benign0.094Likely BenignLikely Benign0.183Likely Benign-1.38Neutral0.997Probably Damaging0.899Possibly Damaging4.07Benign0.04Affected3.883201.3-19.05
c.304T>GL102VLikely BenignUncertain 16-33432169-T-G16.20e-7-4.316Likely Benign0.068Likely BenignLikely Benign0.102Likely Benign0.32Neutral0.880Possibly Damaging0.899Possibly Damaging4.21Benign0.00Affected4.321210.4-14.03
c.2485G>AE829KLikely PathogenicPathogenic 1-7.527In-Between0.807Likely PathogenicAmbiguous0.194Likely Benign-2.65Deleterious0.994Probably Damaging0.900Possibly Damaging2.27Pathogenic0.00Affected3.77501-0.4-0.94
c.2962C>TL988FLikely BenignUncertain 16-33443514-C-T16.20e-7-4.368Likely Benign0.356AmbiguousLikely Benign0.135Likely Benign-1.70Neutral0.977Probably Damaging0.900Possibly Damaging2.69Benign0.00Affected4.32220-1.034.02
c.136C>TP46SLikely BenignUncertain 1-3.338Likely Benign0.302Likely BenignLikely Benign0.066Likely Benign-0.60Neutral0.909Possibly Damaging0.901Possibly Damaging4.15Benign0.00Affected1-10.8-10.04
c.3197C>TP1066LLikely BenignLikely Benign 16-33443749-C-T148.71e-6-5.478Likely Benign0.092Likely BenignLikely Benign0.173Likely Benign-3.68Deleterious0.996Probably Damaging0.903Possibly Damaging2.72Benign0.00Affected4.322-3-35.416.04
c.3980C>TP1327LLikely BenignUncertain 16-33451854-C-T21.28e-6-5.264Likely Benign0.242Likely BenignLikely Benign0.142Likely Benign-1.24Neutral0.994Probably Damaging0.908Possibly Damaging4.12Benign0.10Tolerated3.775-3-35.416.04
c.583G>CA195PLikely PathogenicLikely Pathogenic 1-9.715Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.152Likely Benign-3.03Deleterious0.997Probably Damaging0.916Probably Damaging4.00Benign0.04Affected3.5461-1-3.426.04
c.600G>CL200F
(3D Viewer)
PHUncertain 16-33435242-G-C21.24e-6-7.606In-Between0.592Likely PathogenicLikely Benign0.094Likely Benign1.00Ambiguous0.51.45Ambiguous1.23Ambiguous0.43Likely Benign-1.97Neutral0.997Probably Damaging0.916Probably Damaging4.02Benign0.17Tolerated3.46920-1.034.02250.4-15.10.60.20.50.0XUncertainLeu200, a hydrophobic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another hydrophobic residue, phenylalanine. Both the phenyl group of Phe200 and the branched iso-butyl hydrocarbon sidechain of Leu200 occupy an inward hydrophobic niche (e.g., Leu246, Val222, Phe231) during the simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1417G>AV473I
(3D Viewer)
GAPUncertain 16-33438449-G-A16.20e-7-7.481In-Between0.418AmbiguousLikely Benign0.203Likely Benign-0.12Likely Benign0.01.20Ambiguous0.54Ambiguous-0.06Likely Benign-0.91Neutral0.929Possibly Damaging0.917Probably Damaging3.74Benign0.18Tolerated3.3734340.314.03
c.121C>TR41CLikely BenignConflicting 36-33423530-C-T74.34e-6-4.745Likely Benign0.207Likely BenignLikely Benign0.093Likely Benign-1.10Neutral0.976Probably Damaging0.919Probably Damaging4.13Benign0.00Affected4.321-4-37.0-53.05
c.73C>TR25WLikely BenignUncertain 26-33423482-C-T63.72e-6-5.133Likely Benign0.549AmbiguousLikely Benign0.158Likely Benign-1.60Neutral0.994Probably Damaging0.919Probably Damaging3.92Benign0.00Affected4.321-323.630.03
c.1447A>GI483V
(3D Viewer)
GAPConflicting 2-10.121Likely Pathogenic0.523AmbiguousLikely Benign0.228Likely Benign1.00Ambiguous0.00.27Likely Benign0.64Ambiguous1.02Destabilizing-0.86Neutral0.914Possibly Damaging0.921Probably Damaging3.23Benign0.03Affected3.373234-0.3-14.03
c.3059G>TR1020LUncertain 1-6.031Likely Benign0.907Likely PathogenicAmbiguous0.216Likely Benign-4.03Deleterious0.990Probably Damaging0.921Probably Damaging2.50Benign0.00Affected3.775-3-28.3-43.03
c.1403T>AM468K
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-16.982Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.828Likely Pathogenic3.21Destabilizing0.13.30Destabilizing3.26Destabilizing2.57Destabilizing-4.61Deleterious0.878Possibly Damaging0.922Probably Damaging-1.34Pathogenic0.04Affected3.37310-1-5.8-3.02188.769.30.00.0-0.10.2XXPotentially PathogenicThe thioether group of Met468, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues (e.g., Phe464, Leu465, Leu489) in an inter-helix space formed by two other α helices (res. Ala461–Phe476, res. Thr488–Gly502). In the variant simulations, the positively charged side chain of Lys468 rotates outward to escape the hydrophobic niche, forming an H-bond with the hydroxyl group of the Ser471 side chain and a salt bridge with the carboxylate group of the Glu472 side chain. This residue swap also disrupts the methionine-aromatic stacking with the phenyl ring of the Phe464 side chain. Although no large-scale structural changes are observed during the variant simulations, the importance of hydrophobic packing suggests that the effects could be more pronounced during protein folding.
c.1768A>GS590G
(3D Viewer)
Likely PathogenicGAPConflicting 26-33440820-A-G148.67e-6-14.277Likely Pathogenic0.574Likely PathogenicLikely Benign0.379Likely Benign0.67Ambiguous0.11.28Ambiguous0.98Ambiguous0.71Ambiguous-3.92Deleterious1.000Probably Damaging0.922Probably Damaging3.42Benign0.06Tolerated3.3735100.4-30.03186.749.40.00.00.10.0XPotentially PathogenicIn the WT simulations, the hydroxyl group of Ser590, located on an α helix (res. Glu582-Met603), forms hydrogen bonds with the backbone carbonyl of Ala634 and/or the carboxamide group of the Asn635 side chain at the end of the opposing α helix (res. Thr619-Ala634).The residue swap could weaken the integrity of the α helix, as glycine is known as an “α helix breaker.” However, no discernible difference was observed between the WT and variant simulations in this regard. Importantly, Gly590 cannot form hydrogen bonds with the opposing helix in the same way that serine can, which could weaken the tertiary structure assembly between the two helices.
c.2945A>GY982CLikely BenignLikely Benign 16-33443497-A-G21.24e-6-6.256Likely Benign0.746Likely PathogenicLikely Benign0.195Likely Benign-1.67Neutral0.997Probably Damaging0.923Probably Damaging3.87Benign0.00Affected4.3210-23.8-60.04
c.1752C>GI584M
(3D Viewer)
Likely PathogenicGAPUncertain 26-33440804-C-G16.20e-7-10.119Likely Pathogenic0.419AmbiguousLikely Benign0.478Likely Benign0.11Likely Benign0.10.46Likely Benign0.29Likely Benign1.16Destabilizing-2.62Deleterious0.983Probably Damaging0.925Probably Damaging-1.25Pathogenic0.12Tolerated3.373421-2.618.03247.5-20.3-0.10.3-0.10.1XPotentially BenignA hydrophobic residue, Ile584, located in an α helix (res. Glu582-Met603), is swapped for another hydrophobic residue, Met584. The sec-butyl hydrocarbon side chain of Ile584 packs hydrophobically with residues in an inter-helix hydrophobic space (e.g., Leu588, Met477, Val473, and Ile483).In the variant simulations, the thioether hydrophobic side chain of Met584 maintains similar interactions as Ile584 in the WT, as it is roughly the same size and fits well within the hydrophobic space. Thus, the residue swap does not appear to cause any negative effects on the protein structure.
c.113C>TP38LLikely BenignConflicting 46-33423522-C-T84.96e-6-2.469Likely Benign0.197Likely BenignLikely Benign0.141Likely Benign-2.56Deleterious0.983Probably Damaging0.931Probably Damaging4.02Benign0.00Affected4.321-3-35.416.04
c.2420A>GY807CSH3-binding motifUncertain 16-33442972-A-G16.20e-7-7.228In-Between0.204Likely BenignLikely Benign0.243Likely Benign-3.89Deleterious0.997Probably Damaging0.934Probably Damaging2.42Pathogenic0.01Affected3.7750-23.8-60.04
c.2003C>TS668F
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-15.047Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.643Likely Pathogenic16.72Destabilizing5.011.07Destabilizing13.90Destabilizing0.00Likely Benign-5.98Deleterious0.999Probably Damaging0.935Probably Damaging3.18Benign0.00Affected3.3828-3-23.660.10250.9-59.6-0.10.10.00.1XXXPotentially PathogenicIn the WT simulations, the hydroxyl side chain of Ser668, located on an α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), forms hydrogen bonds with the backbone carbonyl groups of Leu664, Tyr665, and Glu666, as well as the guanidinium group of Arg573 on a nearby α-helix (res. Arg563-Glu578). In the variant simulations, the side chain of Phe668 cannot maintain the same hydrogen-bond network. Due to its larger size, it moves away to avoid steric hindrance. In the WT simulations, a network of hydrogen bonds between several residues (e.g., Asn669, Lys566, and Glu666) keeps both α-helices and the proceeding loop (res. Asn669-Asp684) tightly connected, but this setup is not present in the variant simulations. Additionally, in the variant simulations, the side chain of Arg573 shifts to form a more stable salt bridge with the carboxylate group of Glu582 instead of hydrogen bonding with Ser668 as in the WT simulations.
c.1259T>CF420S
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-13.231Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.544Likely Pathogenic5.34Destabilizing0.15.73Destabilizing5.54Destabilizing2.14Destabilizing-7.43Deleterious0.998Probably Damaging0.938Probably Damaging3.09Benign0.00Affected3.3729-3-2-3.6-60.10213.357.80.00.0-0.40.1XPotentially PathogenicIn the WT, the phenyl ring of the Phe420 side chain, located on an α helix (res. Met414-Glu436), packs against hydrophobic residues in the interhelix area of the GAP domain (e.g., Leu689, Leu714, Leu717, Leu718). Although no large-scale adverse effects are seen in the variant simulations, the polar hydroxyl group of Ser420 is not suitable for the hydrophobic inter-helix space. Thus, the residue swap could affect protein folding. In theory, the introduced hydroxyl group could also lower the α helix integrity by H-bonding with the backbone atoms of neighboring residues in the same α helix. However, no such effect is seen in the variant simulations.
c.2218C>TR740WUncertain 26-33441683-C-T63.72e-6-8.561Likely Pathogenic0.168Likely BenignLikely Benign0.180Likely Benign-3.09Deleterious1.000Probably Damaging0.938Probably Damaging2.52Benign0.01Affected4.3222-33.630.03
c.2835T>AH945QLikely BenignConflicting 26-33443387-T-A31.86e-6-5.248Likely Benign0.091Likely BenignLikely Benign0.343Likely Benign-0.36Neutral0.995Probably Damaging0.939Probably Damaging5.03Benign0.06Tolerated4.32430-0.3-9.01
c.1635G>AM545I
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.348Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.592Likely Pathogenic0.47Likely Benign0.10.14Likely Benign0.31Likely Benign0.63Ambiguous-3.61Deleterious0.935Possibly Damaging0.941Probably Damaging-1.27Pathogenic0.28Tolerated3.3735122.6-18.03
c.2195G>AR732KLikely BenignConflicting 26-33441660-G-A42.48e-6-5.278Likely Benign0.240Likely BenignLikely Benign0.045Likely Benign-0.82Neutral0.973Probably Damaging0.943Probably Damaging2.69Benign0.21Tolerated3.597320.6-28.01
c.2324G>CR775PLikely BenignBenign 1-5.072Likely Benign0.452AmbiguousLikely Benign0.168Likely Benign-0.79Neutral0.971Probably Damaging0.944Probably Damaging4.13Benign0.07Tolerated3.646-202.9-59.07
c.1221G>TQ407H
(3D Viewer)
Likely PathogenicC2Uncertain 1-10.526Likely Pathogenic0.830Likely PathogenicAmbiguous0.206Likely Benign0.59Ambiguous0.00.61Ambiguous0.60Ambiguous1.10Destabilizing-4.51Deleterious0.982Probably Damaging0.947Probably Damaging3.88Benign0.01Affected3.3828030.39.01
c.2354G>AR785HSH3-binding motifUncertain 26-33442906-G-A42.50e-6-4.782Likely Benign0.388AmbiguousLikely Benign0.129Likely Benign-2.61Deleterious0.999Probably Damaging0.947Probably Damaging2.25Pathogenic0.01Affected3.646201.3-19.05
c.2560C>TR854CLikely BenignUncertain 16-33443112-C-T31.86e-6-5.082Likely Benign0.170Likely BenignLikely Benign0.174Likely Benign-2.48Neutral1.000Probably Damaging0.947Probably Damaging4.05Benign0.01Affected3.883-3-47.0-53.05
c.742C>TR248W
(3D Viewer)
Likely PathogenicPHUncertain 1-11.647Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.699Likely Pathogenic1.17Ambiguous0.3-0.20Likely Benign0.49Likely Benign0.89Ambiguous-6.98Deleterious1.000Probably Damaging0.948Probably Damaging5.62Benign0.00Affected3.41142-33.630.03266.442.30.00.00.30.1XPotentially PathogenicThe guanidinium group of Arg248, located on an α helix (res. Ala236-Val250), forms two very stable salt bridges with Asp255 (from a short α helical section, res. Lys254-Asn256) and Glu244 (from a nearby loop) in the WT simulations. In the variant simulations, the indole group of Trp248 cannot form any salt bridges, which could negatively affect the tertiary structure assembly of the PH domain. Instead, in the variant simulations, the indole ring of Trp248 stacks against Pro252, which makes a turn after the α helix.
c.3631A>GM1211VLikely BenignCoiled-coilBenign 16-33446623-A-G31.86e-6-2.101Likely Benign0.258Likely BenignLikely Benign0.412Likely Benign-0.29Neutral0.932Possibly Damaging0.949Probably Damaging5.43Benign0.72Tolerated3.775122.3-32.06
c.2294G>AS765NLikely BenignUncertain 1-5.098Likely Benign0.378AmbiguousLikely Benign0.094Likely Benign-0.94Neutral0.985Probably Damaging0.950Probably Damaging4.11Benign0.06Tolerated3.64611-2.727.03
c.1306G>AE436K
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.869Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.829Likely Pathogenic0.56Ambiguous0.12.86Destabilizing1.71Ambiguous0.82Ambiguous-3.77Deleterious0.994Probably Damaging0.951Probably Damaging4.71Benign0.02Affected3.372901-0.4-0.94186.839.80.00.0-0.20.0XXXPotentially PathogenicThe carboxylate group of Glu436, located on the α helix (res. Met414-Glu436), forms a salt bridge with the amino group of the Lys444 side chain on an opposing α helix (res. Val441-Ser457). The backbone carbonyl of Glu436 also H-bonds with the Lys444 side chain, which helps keep the ends of the two α helices tightly connected. In contrast, in the variant simulations, the salt bridge formation with Lys444 is not possible. Instead, the repelled Lys436 side chain rotates outward, causing a change in the α helix backbone H-bonding: the amide group of Lys444 H-bonds with the carbonyl of Ala433 instead of the carbonyl of Cys432.
c.2071A>CT691P
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-13.801Likely Pathogenic0.905Likely PathogenicAmbiguous0.214Likely Benign5.04Destabilizing0.46.09Destabilizing5.57Destabilizing1.27Destabilizing-3.43Deleterious1.000Probably Damaging0.952Probably Damaging3.43Benign0.06Tolerated3.43140-1-0.9-3.99188.933.00.10.0-0.60.0XXPotentially PathogenicThe hydroxyl side chain of Thr691, located in an α-helix (res. Leu696-Leu685), can form hydrogen bonds with the backbone carbonyl and the side chain guanidinium group of Arg687. This interaction facilitates the simultaneous formation of salt bridges between Arg687 and Glu688 on the same α-helix. Additionally, Thr691 occasionally interacts with the thioether side chain of Met409 in an anti-parallel β-sheet of the C2 domain (res. Ile411-Ala399), although this interaction is not consistently maintained throughout the WT simulations. In the variant simulations, the pyrrolidine side chain of Pro691 lacks hydrogen bond donors, making a similar setup impossible. Moreover, proline lacks a free amide group necessary for hydrogen bonding with the carbonyl group of Arg687, introducing a slight bend in the α-helix and compromising its integrity.
c.323A>GK108RLikely BenignUncertain 16-33432188-A-G63.72e-6-2.892Likely Benign0.148Likely BenignLikely Benign0.184Likely Benign0.37Neutral0.993Probably Damaging0.956Probably Damaging4.22Benign1.00Tolerated3.61532-0.628.01
c.1481T>GI494R
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-15.758Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.911Likely Pathogenic6.71Destabilizing0.33.40Destabilizing5.06Destabilizing2.19Destabilizing-6.43Deleterious0.999Probably Damaging0.957Probably Damaging-1.41Pathogenic0.00Affected3.3735-2-3-9.043.03273.9-59.80.00.00.00.1XXXXPotentially PathogenicThe sec-butyl side chain of Ile494, located in an α-helix (res. Leu489-Glu519), packs against hydrophobic residues (e.g., Phe484, Leu465, Trp572, Ala493, Met468) in an inter-helix space (res. Leu489-Glu519 and res. Ala461-Phe476). In the variant simulations, the bulkier and positively charged residue, Arg494, weakens the integrity of the opposing helix. Additionally, the bulkier Arg494 stacks with Phe484, causing the α-helices to move farther apart to accommodate it. This mutation could have substantial negative effects due to the fundamental role of hydrophobic packing, which is disrupted by Arg494 during protein folding.
c.3223C>AQ1075KLikely BenignUncertain 1-5.135Likely Benign0.728Likely PathogenicLikely Benign0.134Likely Benign-0.67Neutral0.963Probably Damaging0.959Probably Damaging2.75Benign1.00Tolerated3.77511-0.40.04
c.2434C>TP812SLikely BenignSH3-binding motifUncertain 16-33442986-C-T16.20e-7-5.689Likely Benign0.456AmbiguousLikely Benign0.162Likely Benign-0.62Neutral0.999Probably Damaging0.966Probably Damaging2.89Benign0.95Tolerated4.3241-10.8-10.04
c.453C>AD151ELikely BenignUncertain 1-5.662Likely Benign0.886Likely PathogenicAmbiguous0.142Likely Benign-2.02Neutral0.984Probably Damaging0.967Probably Damaging3.99Benign0.11Tolerated3.615320.014.03
c.1150G>AG384S
(3D Viewer)
Likely BenignC2Uncertain 16-33438055-G-A16.22e-7-5.243Likely Benign0.090Likely BenignLikely Benign0.315Likely Benign1.92Ambiguous0.21.66Ambiguous1.79Ambiguous0.19Likely Benign-0.67Neutral0.980Probably Damaging0.968Probably Damaging1.33Pathogenic0.04Affected4.32210-0.430.03202.4-49.80.51.0-0.20.0UncertainGly384 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and so they are rich in glycines, prolines, and, to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Ser384 is potentially tolerated in the Ω loop, although the hydroxyl group of Ser384 forms various hydrogen bonds with several other loop residues in the variant simulations. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1154C>GS385W
(3D Viewer)
C2Benign 16-33438059-C-G-9.353Likely Pathogenic0.362AmbiguousLikely Benign0.373Likely Benign0.53Ambiguous0.20.69Ambiguous0.61Ambiguous0.00Likely Benign-0.84Neutral0.986Probably Damaging0.968Probably Damaging4.63Benign0.00Affected4.323-2-3-0.199.14260.4-71.20.51.30.70.4UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like tryptophan are rarely tolerated. Although no major negative structural effects are observed in the variant simulations, Trp385 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.10.1016/j.ajhg.2020.11.011
c.2282G>CR761PLikely BenignUncertain 36-33441747-G-C16.20e-7-5.091Likely Benign0.640Likely PathogenicLikely Benign0.201Likely Benign-1.89Neutral0.999Probably Damaging0.968Probably Damaging2.69Benign0.38Tolerated3.9950-22.9-59.07
c.3633G>AM1211ILikely BenignCoiled-coilUncertain 16-33446625-G-A31.86e-6-1.537Likely Benign0.764Likely PathogenicLikely Benign0.298Likely Benign-0.42Neutral0.969Probably Damaging0.968Probably Damaging5.40Benign1.00Tolerated3.775122.6-18.03
c.3958C>TP1320SLikely BenignUncertain 16-33451832-C-T21.28e-6-4.928Likely Benign0.073Likely BenignLikely Benign0.097Likely Benign-0.69Neutral0.980Probably Damaging0.968Probably Damaging4.25Benign0.00Affected3.7751-10.8-10.04
c.455G>AR152QUncertain 16-33432752-G-A53.14e-6-10.336Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.181Likely Benign-2.34Neutral0.997Probably Damaging0.968Probably Damaging3.89Benign0.00Affected3.615111.0-28.06
c.2113A>CK705Q
(3D Viewer)
Likely BenignGAPUncertain 16-33441372-A-C16.20e-7-5.787Likely Benign0.436AmbiguousLikely Benign0.142Likely Benign-0.10Likely Benign0.00.33Likely Benign0.12Likely Benign-0.02Likely Benign-0.24Neutral0.997Probably Damaging0.969Probably Damaging3.42Benign0.78Tolerated3.4710110.4-0.04
c.968T>GL323R
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-14.568Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.692Likely Pathogenic3.75Destabilizing0.44.47Destabilizing4.11Destabilizing2.15Destabilizing-4.70Deleterious0.999Probably Damaging0.969Probably Damaging0.59Pathogenic0.01Affected3.3922-3-2-8.343.03261.8-61.6-0.40.20.80.2XXXPotentially PathogenicThe iso-butyl side chain of Leu323, located at the beginning of an anti-parallel β sheet strand (res. Ala322-Asp330), packs against multiple hydrophobic leucine residues (e.g., Leu264, Leu266, Leu284, Leu286). In contrast, in the variant simulations, the positively charged guanidinium group of the Arg323 side chain is unsuitable for the hydrophobic niche. Consequently, the side chain either rotates away from the center of the C2 domain or, if it remains within the C2 domain core, it reorients nearby residues to form hydrogen bonds. Regardless, the residue swap extensively disrupts the C2 domain structure.
c.2086C>GL696V
(3D Viewer)
Likely PathogenicGAPUncertain 1-11.909Likely Pathogenic0.745Likely PathogenicLikely Benign0.351Likely Benign2.35Destabilizing0.11.85Ambiguous2.10Destabilizing1.46Destabilizing-2.79Deleterious0.992Probably Damaging0.970Probably Damaging3.16Benign0.00Affected3.4613120.4-14.03
c.2131C>GL711V
(3D Viewer)
Likely PathogenicGAPUncertain16-33441596-C-G16.20e-7-10.045Likely Pathogenic0.709Likely PathogenicLikely Benign0.170Likely Benign3.48Destabilizing0.12.22Destabilizing2.85Destabilizing1.40Destabilizing-2.59Deleterious0.992Probably Damaging0.970Probably Damaging3.34Benign0.00Affected3.509120.4-14.03
c.1997A>GE666G
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33441256-A-G106.20e-6-12.261Likely Pathogenic0.911Likely PathogenicAmbiguous0.522Likely Pathogenic1.57Ambiguous0.11.46Ambiguous1.52Ambiguous0.93Ambiguous-6.25Deleterious1.000Probably Damaging0.970Probably Damaging3.37Benign0.02Affected3.38280-23.1-72.06173.998.50.00.0-0.70.0XPotentially PathogenicIn the WT simulations, the carboxylate group of Glu666, located on the α-helix (res. Ser641-Glu666), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), such as Lys566, Thr672, and Asn669. In the variant simulations, the carbonyl group of Gly666 occasionally forms hydrogen bonds with Lys566 and Asn669. However, Gly666 lacks a side chain and thus cannot maintain as well-coordinated a hydrogen-bond network as Glu666 in the WT, which may affect the tertiary structure assembly.
c.767A>GN256S
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-10.640Likely Pathogenic0.950Likely PathogenicAmbiguous0.707Likely Pathogenic0.31Likely Benign0.20.36Likely Benign0.34Likely Benign0.48Likely Benign-4.33Deleterious0.997Probably Damaging0.970Probably Damaging5.87Benign0.02Affected3.3915112.7-27.03
c.2668C>TR890CBenign 16-33443220-C-T95.58e-6-5.786Likely Benign0.402AmbiguousLikely Benign0.200Likely Benign-3.38Deleterious1.000Probably Damaging0.971Probably Damaging3.94Benign0.04Affected4.324-4-37.0-53.05
c.2050G>CD684H
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.194Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.613Likely Pathogenic3.36Destabilizing1.02.95Destabilizing3.16Destabilizing0.55Ambiguous-6.98Deleterious1.000Probably Damaging0.972Probably Damaging3.36Benign0.00Affected3.4217-110.322.05
c.3262A>GS1088GLikely BenignUncertain 1-5.034Likely Benign0.285Likely BenignLikely Benign0.163Likely Benign-1.83Neutral0.979Probably Damaging0.973Probably Damaging2.63Benign0.03Affected3.775010.4-30.03
c.3862A>GK1288EUncertain 16-33447910-A-G53.22e-6-2.751Likely Benign0.407AmbiguousLikely Benign0.185Likely Benign-3.27Deleterious0.979Probably Damaging0.973Probably Damaging2.13Pathogenic0.00Affected3.775100.40.94
c.2518A>TS840CLikely PathogenicUncertain 1-8.799Likely Pathogenic0.904Likely PathogenicAmbiguous0.376Likely Benign-3.96Deleterious0.999Probably Damaging0.975Probably Damaging1.50Pathogenic0.00Affected3.7750-13.316.06
c.2809G>CD937HLikely BenignUncertain 1-0.733Likely Benign0.677Likely PathogenicLikely Benign0.150Likely Benign-1.74Neutral1.000Probably Damaging0.975Probably Damaging2.68Benign0.13Tolerated3.775-110.322.05
c.1942T>CF648LLikely PathogenicGAPUncertain 1-9.296Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.468Likely Benign2.71Destabilizing0.82.08Destabilizing2.40Destabilizing1.04Destabilizing-5.98Deleterious0.999Probably Damaging0.976Probably Damaging3.45Benign0.08Tolerated201.0-34.02
c.1505G>AG502D
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.796Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.915Likely Pathogenic3.79Destabilizing0.95.69Destabilizing4.74Destabilizing1.38Destabilizing-6.80Deleterious0.999Probably Damaging0.977Probably Damaging-1.66Pathogenic0.00Affected3.37351-1-3.158.04224.2-80.0-0.80.70.60.3XXXPotentially PathogenicGly502 is located in a hinge in the middle of an α-helix (res. Leu489-Glu519). In the WT, Gly502 acts as an α-helix breaker due to its lack of a side chain, facilitating a bend in the middle of the α-helix. In the variant simulations, the carboxylate group of Asp502 forms hydrogen bonds with neighboring residues (e.g., Ser677, Lys504), disrupting the hinge. Additionally, Asp502 struggles to fit into the α-helix hinge and cannot generate a similar bend as Gly502, which would drastically affect the secondary structure during folding. Thus, the deleterious effect seen in the simulations is likely an underestimate of the impact of the residue swap on the protein structure during protein folding.
c.2458T>AY820NUncertain 1-9.032Likely Pathogenic0.842Likely PathogenicAmbiguous0.143Likely Benign-1.53Neutral0.999Probably Damaging0.977Probably Damaging2.74Benign0.20Tolerated-2-2-2.2-49.07
c.2503C>AL835MLikely BenignBenign 1-4.153Likely Benign0.121Likely BenignLikely Benign0.068Likely Benign-0.45Neutral0.999Probably Damaging0.977Probably Damaging2.67Benign0.12Tolerated3.77524-1.918.03
c.2669G>CR890PLikely BenignLikely Benign 26-33443221-G-C281.74e-5-1.931Likely Benign0.301Likely BenignLikely Benign0.191Likely Benign-1.21Neutral0.999Probably Damaging0.977Probably Damaging4.02Benign0.28Tolerated4.3240-22.9-59.07
c.2735C>AT912NLikely BenignUncertain 1-4.260Likely Benign0.190Likely BenignLikely Benign0.116Likely Benign-1.15Neutral0.999Probably Damaging0.977Probably Damaging3.96Benign0.00Affected3.77500-2.813.00
c.3059G>CR1020PLikely PathogenicUncertain 1-3.491Likely Benign0.902Likely PathogenicAmbiguous0.205Likely Benign-3.50Deleterious0.999Probably Damaging0.977Probably Damaging2.46Pathogenic0.00Affected0-22.9-59.07
c.968T>CL323P
(3D Viewer)
Likely PathogenicC2Uncertain 1-12.507Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.762Likely Pathogenic3.39Destabilizing0.68.46Destabilizing5.93Destabilizing2.20Destabilizing-4.80Deleterious0.999Probably Damaging0.977Probably Damaging0.59Pathogenic0.01Affected4.29398-3-3-5.4-16.04201.968.20.00.10.60.3XPotentially PathogenicThe iso-butyl side chain of Leu323, located at the beginning of an anti-parallel β sheet strand (res. Ala322-Asp330), packs against multiple hydrophobic leucine residues (e.g., Leu264, Leu266, Leu284, Leu286). In contrast, in the variant simulations, the less bulky cyclic five-membered pyrrolidine ring of Pro323 cannot fill the hydrophobic space as effectively as the branched hydrocarbon side chain of leucine. Notably, the backbone amide group of Leu323 forms a hydrogen bond with the backbone carbonyl group of Cys285. Pro323 cannot form this bond due to the absence of the backbone amide group, resulting in partial unfolding of the anti-parallel β sheet end in the variant simulations.
c.1202G>AR401Q
(3D Viewer)
Likely PathogenicC2Uncertain 16-33438107-G-A-11.213Likely Pathogenic0.969Likely PathogenicLikely Pathogenic0.780Likely Pathogenic0.96Ambiguous0.11.50Ambiguous1.23Ambiguous1.20Destabilizing-3.69Deleterious0.999Probably Damaging0.978Probably Damaging5.47Benign0.04Affected3.3827111.0-28.06
c.1428C>GF476L
(3D Viewer)
GAPUncertain 26-33438460-C-G42.48e-6-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.180Likely Benign1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.4022201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1082A>CQ361P
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-13.280Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.482Likely Benign3.12Destabilizing0.03.45Destabilizing3.29Destabilizing0.38Likely Benign-3.03Deleterious0.996Probably Damaging0.979Probably Damaging1.63Pathogenic0.05Affected3.3725-101.9-31.01
c.1286G>AR429Q
(3D Viewer)
Likely BenignGAPUncertain 26-33438191-G-A106.20e-6-8.227Likely Pathogenic0.143Likely BenignLikely Benign0.156Likely Benign0.45Likely Benign0.10.36Likely Benign0.41Likely Benign0.98Ambiguous-1.25Neutral1.000Probably Damaging0.979Probably Damaging3.47Benign0.58Tolerated3.3825111.0-28.06235.859.50.00.0-0.30.4XPotentially PathogenicThe guanidinium group of the Arg429 side chain, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or an H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, Gln429 cannot form ionic interactions with the acidic residues; however, the carboxamide group can form multiple H-bonds. The H-bonding coordination of the Asn429 side chain varied between the replica simulations. In one simulation, three H-bonds were formed simultaneously with the Asp467 side chain, the backbone carbonyl group of Asn426, and the amide group of Met430 at the end of the same α helix. The residue swap could affect the tertiary structure assembly during folding due to weaker bond formation, but no large-scale negative effects were seen during the simulations.
c.1441C>TH481Y
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33438473-C-T169.91e-6-10.910Likely Pathogenic0.565Likely PathogenicLikely Benign0.256Likely Benign-0.53Ambiguous0.1-0.46Likely Benign-0.50Ambiguous0.20Likely Benign-3.32Deleterious0.988Probably Damaging0.979Probably Damaging3.40Benign0.59Tolerated3.3733021.926.03256.5-44.40.00.00.20.2XXUncertainThe imidazole ring of the His481 side chain is located in a short helical structure (res. Glu480-Leu482) within an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. In the WT simulations, His481 alternately stacks against Arg485, Arg587, and Glu480 without a definite role. In the variant simulations, Tyr481 also alternately stacks with nearby arginine residues, including Arg485, Arg587, and Arg479. The interaction between Tyr481 and Arg479 affects the α-α loop, causing it to fold into a distorted helical structure, an effect that might be more pronounced during protein folding. Finally, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1851G>TE617D
(3D Viewer)
Likely BenignGAPUncertain 1-1.349Likely Benign0.241Likely BenignLikely Benign0.322Likely Benign0.12Likely Benign0.10.80Ambiguous0.46Likely Benign0.07Likely Benign-0.01Neutral0.994Probably Damaging0.979Probably Damaging-1.35Pathogenic0.88Tolerated3.3735230.0-14.03
c.3632T>AM1211KLikely PathogenicCoiled-coilLikely Benign 1-9.013Likely Pathogenic0.662Likely PathogenicLikely Benign0.595Likely Pathogenic-2.95Deleterious0.987Probably Damaging0.979Probably Damaging5.59Benign0.01Affected3.7750-1-5.8-3.02
c.2713C>TR905CConflicting 26-33443265-C-T159.31e-6-5.578Likely Benign0.723Likely PathogenicLikely Benign0.194Likely Benign-3.14Deleterious1.000Probably Damaging0.980Probably Damaging2.57Benign0.01Affected3.775-4-37.0-53.05
c.1971G>CW657CLikely PathogenicGAPUncertain 1-12.035Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.463Likely Benign2.74Destabilizing0.31.69Ambiguous2.22Destabilizing1.30Destabilizing-11.06Deleterious1.000Probably Damaging0.982Probably Damaging3.43Benign0.03Affected-8-23.4-83.07
c.2249G>AG750EUncertain 1-2.618Likely Benign0.413AmbiguousLikely Benign0.146Likely Benign-2.27Neutral1.000Probably Damaging0.982Probably Damaging2.49Pathogenic0.01Affected3.9950-2-3.172.06
c.2362T>AS788TLikely BenignSH3-binding motifUncertain 26-33442914-T-A42.49e-6-4.288Likely Benign0.288Likely BenignLikely Benign0.092Likely Benign-2.25Neutral0.979Probably Damaging0.982Probably Damaging1.55Pathogenic0.02Affected3.646110.114.03
c.2459A>GY820CLikely PathogenicUncertain 1-8.797Likely Pathogenic0.744Likely PathogenicLikely Benign0.113Likely Benign-3.16Deleterious1.000Probably Damaging0.983Probably Damaging2.68Benign0.06Tolerated3.7750-23.8-60.04
c.3640C>TR1214WLikely PathogenicCoiled-coilUncertain 16-33446632-C-T21.24e-6-8.799Likely Pathogenic0.710Likely PathogenicLikely Benign0.143Likely Benign-4.95Deleterious1.000Probably Damaging0.983Probably Damaging2.45Pathogenic0.00Affected3.7752-33.630.03
c.718G>AD240NLikely PathogenicPHUncertain 1-12.942Likely Pathogenic0.755Likely PathogenicLikely Benign0.701Likely Pathogenic0.22Likely Benign0.90.47Likely Benign0.35Likely Benign0.37Likely Benign-4.37Deleterious0.993Probably Damaging0.984Probably Damaging5.88Benign0.01Affected210.0-0.98
c.719A>GD240GLikely PathogenicPHUncertain 1-12.825Likely Pathogenic0.951Likely PathogenicAmbiguous0.912Likely Pathogenic1.85Ambiguous0.12.72Destabilizing2.29Destabilizing0.24Likely Benign-6.19Deleterious0.993Probably Damaging0.984Probably Damaging5.79Benign0.01Affected1-13.1-58.04
c.1403T>CM468T
(3D Viewer)
Likely PathogenicGAPUncertain 26-33438435-T-C16.20e-7-12.399Likely Pathogenic0.862Likely PathogenicAmbiguous0.801Likely Pathogenic3.47Destabilizing0.13.10Destabilizing3.29Destabilizing1.84Destabilizing-3.85Deleterious0.994Probably Damaging0.985Probably Damaging-1.31Pathogenic0.01Affected3.3731-1-1-2.6-30.09214.647.10.00.00.10.0XPotentially PathogenicThe thioether group of Met468, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues (e.g., Phe464, Leu465, Leu489) in an inter-helix space formed by two other α helices (res. Ala461–Phe476, res. Thr488–Gly502). In the variant simulations, the hydrophilic side chain of Thr468 does not pack favorably in the hydrophobic niche, and the methionine-aromatic stacking is lost. Although the hydroxyl group of Thr468 forms an H-bond with the backbone carbonyl group of Phe464, the integrity of the α helix is not affected in the simulations. No large-scale structural changes are observed during the variant simulations; however, due to the importance of hydrophobic packing, the effects could be more pronounced during protein folding.
c.1409T>CM470T
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.104Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.763Likely Pathogenic3.19Destabilizing0.12.68Destabilizing2.94Destabilizing1.49Destabilizing-5.30Deleterious0.996Probably Damaging0.985Probably Damaging-1.08Pathogenic0.24Tolerated3.3734-1-1-2.6-30.09213.846.50.00.0-0.20.2XXPotentially PathogenicThe thioether group of Met470, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues in the inter-helix space (e.g., Val473, Leu558, Cys576, Trp572) formed by two other α helices (res. Ser604–Arg581, res. Pro562–Arg579). In the WT simulations, the Met470 side chain also packs against the positively charged guanidinium groups of Arg575, Arg429, and Arg579, which form salt bridges with the negatively charged carboxylate groups of the Asp474 and Asp467 side chains at the protein surface. In the variant simulations, the hydroxyl group of the Thr470 side chain forms an H-bond with the backbone carbonyl group of Ser466 in the α helix, potentially lowering its structural integrity. Importantly, the hydroxyl group of Thr470 also forms an H-bond with the guanidinium group of Arg575, which helps it form a more permanent salt bridge with Asp467.
c.2812G>AG938RLikely BenignUncertain 1-5.271Likely Benign0.732Likely PathogenicLikely Benign0.141Likely Benign-1.11Neutral0.999Probably Damaging0.985Probably Damaging2.74Benign0.36Tolerated3.775-3-2-4.199.14
c.1405G>AA469T
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.540Likely Pathogenic0.723Likely PathogenicLikely Benign0.527Likely Pathogenic2.26Destabilizing0.11.90Ambiguous2.08Destabilizing0.34Likely Benign-1.46Neutral0.994Probably Damaging0.986Probably Damaging-1.21Pathogenic0.42Tolerated10-2.530.03
c.1558T>CS520P
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.707Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.855Likely Pathogenic3.72Destabilizing0.88.86Destabilizing6.29Destabilizing0.83Ambiguous-4.57Deleterious0.997Probably Damaging0.986Probably Damaging-1.32Pathogenic0.01Affected1-1-0.810.04
c.2741A>TD914VLikely BenignUncertain 1-4.260Likely Benign0.723Likely PathogenicLikely Benign0.187Likely Benign-2.24Neutral0.999Probably Damaging0.986Probably Damaging2.64Benign0.01Affected3.775-3-27.7-15.96
c.1067G>AR356H
(3D Viewer)
Likely PathogenicC2Likely Benign 16-33437972-G-A95.66e-6-11.453Likely Pathogenic0.614Likely PathogenicLikely Benign0.314Likely Benign0.59Ambiguous0.1-0.27Likely Benign0.16Likely Benign1.17Destabilizing-4.43Deleterious0.999Probably Damaging0.987Probably Damaging1.70Pathogenic0.01Affected3.3922021.3-19.05
c.1240A>GM414VGAPUncertain 1-8.003Likely Pathogenic0.541AmbiguousLikely Benign0.261Likely Benign1.81Ambiguous0.41.73Ambiguous1.77Ambiguous0.95Ambiguous-2.95Deleterious0.999Probably Damaging0.987Probably Damaging3.43Benign0.24Tolerated212.3-32.06
c.1729G>AA577T
(3D Viewer)
Likely BenignGAPBenign 16-33440781-G-A63.72e-6-5.311Likely Benign0.322Likely BenignLikely Benign0.427Likely Benign0.86Ambiguous0.10.54Ambiguous0.70Ambiguous0.54Ambiguous-1.47Neutral0.999Probably Damaging0.987Probably Damaging-1.31Pathogenic0.47Tolerated3.373410-2.530.03191.9-43.40.00.00.70.1XPotentially BenignAla577 is located near the end and outer surface of an α-helix (res. Arg563-Glu578), where its methyl group does not form any particular interactions in the WT simulations. In the variant simulations, the hydroxyl group of the Thr577 side chain hydrogen bonds with the backbone atoms of Arg573 and Lys574 within the same helix, which has the potential to weaken the stability of the secondary structure element. Regardless, the residue swap seems to be well tolerated based on the variant simulations.
c.3661C>TR1221WLikely PathogenicCoiled-coilConflicting 36-33446653-C-T16.20e-7-10.938Likely Pathogenic0.651Likely PathogenicLikely Benign0.174Likely Benign-4.57Deleterious1.000Probably Damaging0.987Probably Damaging2.50Benign0.01Affected3.7752-33.630.03
c.470G>AR157HUncertain 16-33432767-G-A16.20e-7-10.235Likely Pathogenic0.604Likely PathogenicLikely Benign0.254Likely Benign-2.23Neutral0.999Probably Damaging0.987Probably Damaging3.80Benign0.00Affected3.744201.3-19.05
c.886T>GS296A
(3D Viewer)
Likely BenignC2Uncertain 1-6.847Likely Benign0.247Likely BenignLikely Benign0.209Likely Benign0.50Ambiguous0.3-0.26Likely Benign0.12Likely Benign0.35Likely Benign-1.79Neutral0.992Probably Damaging0.987Probably Damaging1.97Pathogenic0.65Tolerated3.4016112.6-16.00182.526.6-0.20.1-0.50.0XPotentially PathogenicThe hydroxyl group of the Ser296 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), stably hydrogen bonds with the carboxylate group of Asp330 in a neighboring β strand (res. Ala322-Asp332). The backbone carbonyl group of Ser296 also hydrogen bonds with the guanidinium group of Arg279 in another nearby β strand (res. Arg279-Cys285). In the variant simulations, the methyl group of the Ala296 side chain cannot hydrogen bond with Asp330, causing the carboxylate group positioning to fluctuate more than in the WT simulations.Although the residue swap does not seem to affect the anti-parallel β sheet assembly during the simulations, it is possible that the Ser296-Asp330 hydrogen bond plays a crucial role in maintaining the C2 domain fold. Notably, because Ser296 is located near the membrane interface, the potential effect of the residue swap on the SynGAP-membrane association cannot be addressed by solvent-only simulations.
c.1456G>AE486K
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.545Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.435Likely Benign0.06Likely Benign0.10.37Likely Benign0.22Likely Benign0.41Likely Benign-3.58Deleterious1.000Probably Damaging0.988Probably Damaging3.40Benign0.12Tolerated3.373501-0.4-0.94206.852.1-0.30.10.20.0XXUncertainGlu486 is located in an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. It is adjacent to the arginine finger (Arg485) and is expected to closely interact with Ras. The residue swap could affect complex formation with the GTPase and its activation. In the WT simulations, the carboxylate group of Glu486 forms salt bridges with Arg485 and Arg475 on the preceding α-helix (res. Ala461-Phe476). In the variant simulations, Lys486 does not form any specific interactions. Although the amino group of the Lys486 side chain cannot form these salt bridges, no negative effects on the protein structure are observed. Nevertheless, the potential role of Glu486 in SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations, and no definite conclusions can be drawn.
c.2684G>AS895NLikely BenignUncertain 1-6.399Likely Benign0.604Likely PathogenicLikely Benign0.118Likely Benign-0.85Neutral0.991Probably Damaging0.988Probably Damaging2.64Benign0.30Tolerated4.32411-2.727.03
c.2719A>TS907CLikely BenignLikely Benign 1-6.685Likely Benign0.298Likely BenignLikely Benign0.113Likely Benign-2.34Neutral0.999Probably Damaging0.988Probably Damaging2.60Benign0.02Affected3.7750-13.316.06
c.2948G>AS983NLikely Benign 16-33443500-G-A63.72e-6-5.604Likely Benign0.909Likely PathogenicAmbiguous0.136Likely Benign-1.78Neutral0.991Probably Damaging0.988Probably Damaging2.04Pathogenic0.00Affected4.32111-2.727.03
c.2954G>AS985NLikely BenignUncertain 1-6.979Likely Benign0.845Likely PathogenicAmbiguous0.088Likely Benign-1.68Neutral0.991Probably Damaging0.988Probably Damaging2.65Benign0.00Affected4.32111-2.727.03
c.3254G>AR1085QLikely BenignUncertain 16-33443806-G-A53.16e-6-3.843Likely Benign0.589Likely PathogenicLikely Benign0.224Likely Benign-1.43Neutral0.998Probably Damaging0.988Probably Damaging2.73Benign0.02Affected3.775111.0-28.06
c.3773A>GQ1258RLikely PathogenicCoiled-coilUncertain 1-10.971Likely Pathogenic0.931Likely PathogenicAmbiguous0.316Likely Benign-3.19Deleterious0.994Probably Damaging0.988Probably Damaging2.00Pathogenic0.00Affected11-1.028.06
c.1485A>CE495D
(3D Viewer)
Likely PathogenicGAPConflicting 2-3.574Likely Benign0.958Likely PathogenicLikely Pathogenic0.566Likely Pathogenic1.39Ambiguous0.11.03Ambiguous1.21Ambiguous0.98Ambiguous-2.52Deleterious0.998Probably Damaging0.989Probably Damaging-1.41Pathogenic0.17Tolerated3.3735320.0-14.03220.638.80.00.00.10.1XXUncertainGlu495 is located in the α-helix (res. Leu489-Glu519), and its carboxylate group forms salt bridges with the neighboring Lys492 and with Arg596 on an opposing α-helix (res. Glu582-Met603) in the WT simulations. In the variant simulations, the acidic carboxylate side chain of Asp495 can also form salt bridges with both Lys492 and Arg596. However, the shorter side chain of aspartate tends to favor forming a salt bridge with the nearby Arg499 on the same α-helix instead. Asp495 might not maintain the salt bridge with Arg596 on the opposing α-helix as efficiently as Glu495 in the WT, potentially weakening the tertiary structure. Regardless, the potential negative effect is likely to be minor, with no deleterious effects observed on the protein structure during the simulations. However, due to its location at the GAP-Ras interface, the effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1625A>GN542S
(3D Viewer)
Likely PathogenicGAPLikely Benign 1-9.675Likely Pathogenic0.767Likely PathogenicLikely Benign0.752Likely Pathogenic0.98Ambiguous0.10.99Ambiguous0.99Ambiguous0.91Ambiguous-4.40Deleterious1.000Probably Damaging0.989Probably Damaging-1.36Pathogenic0.13Tolerated3.3735112.7-27.03212.532.10.00.0-0.60.3XPotentially PathogenicAsn542 is located in an α-helix (res. Ala533-Val560) next to an α-α loop between two α-helices (res. Gly502-Tyr518 and Ala533-Val560). In the WT simulations, the carboxamide group of the Asn542 side chain forms a hydrogen bond with the backbone carbonyl group of Asn523 and packs favourably against Glu522 from the loop. In contrast, in the variant simulations, the hydroxyl group of the Ser542 side chain is unable to maintain either the hydrogen bond with Asn523 or the packing against the Glu522 side chain. Instead, the hydroxyl group of Ser542 occasionally forms a hydrogen bond with the backbone carbonyl group of Glu538.Altogether, the residue swap results in a looser helix-loop association, which is especially evident in the third replica simulation, where Asn523 moves away from its initial placement next to the α-helix. In short, based on the simulations, the residue swap weakens the GAP domain tertiary structure assembly, which in turn could negatively affect protein folding.
c.1667A>GN556S
(3D Viewer)
GAPUncertain 16-33438910-A-G31.86e-6-6.576Likely Benign0.197Likely BenignLikely Benign0.449Likely Benign0.52Ambiguous0.10.14Likely Benign0.33Likely Benign0.16Likely Benign-3.60Deleterious1.000Probably Damaging0.989Probably Damaging-1.22Pathogenic0.14Tolerated3.3735112.7-27.03198.831.00.00.0-0.50.2XPotentially BenignAsn556 is located on the outer surface of an α-helix (res. Ala533-Val560). The carboxamide group of Asn556 forms hydrogen bonds with nearby residues such as Lys553 and Cys552. It also forms a hydrogen bond with the backbone carbonyl group of Cys552, which weakens the α-helix integrity. In the variant simulations, the hydroxyl group of Ser556 forms a more stable hydrogen bond with the backbone carbonyl oxygen of the same helix residue, Cys552, compared to Asn556 in the WT. Serine has a slightly lower propensity to reside in an α-helix than asparagine, which may exacerbate the negative effect on the α-helix integrity. However, the residue swap does not cause negative structural effects during the simulations.
c.1802C>TA601V
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.447Likely Pathogenic0.853Likely PathogenicAmbiguous0.535Likely Pathogenic1.64Ambiguous0.10.35Likely Benign1.00Ambiguous0.81Ambiguous-3.98Deleterious1.000Probably Damaging0.989Probably Damaging2.74Benign0.03Affected3.3735002.428.05228.5-45.50.00.00.40.5XPotentially BenignThe methyl side chain of Ala601, located on an α helix (res. Glu582-Met603), packs hydrophobically against other hydrophobic residues in the inter-helix space (e.g., Phe597, Leu598, Leu506, Phe608).In the variant simulations, Val601, which has similar size and physicochemical properties to alanine, resides in the inter-helix hydrophobic space in a similar manner to Ala601 in the WT, causing no apparent negative effect on the protein structure. However, the effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.2369C>GT790SLikely BenignSH3-binding motifUncertain 1-3.914Likely Benign0.123Likely BenignLikely Benign0.134Likely Benign-1.83Neutral0.997Probably Damaging0.989Probably Damaging2.39Pathogenic0.33Tolerated3.64611-0.1-14.03
c.2522T>CV841AUncertain 16-33443074-T-C31.86e-6-8.152Likely Pathogenic0.901Likely PathogenicAmbiguous0.183Likely Benign-2.13Neutral0.992Probably Damaging0.989Probably Damaging2.57Benign0.02Affected3.77500-2.4-28.05
c.3434A>GN1145SLikely BenignUncertain 16-33444469-A-G21.24e-6-0.989Likely Benign0.126Likely BenignLikely Benign0.308Likely Benign-1.15Neutral0.997Probably Damaging0.989Probably Damaging5.55Benign0.89Tolerated4.324112.7-27.03
c.3567G>CE1189DLikely BenignCoiled-coilLikely Benign 16-33444602-G-C31.86e-6-3.582Likely Benign0.461AmbiguousLikely Benign0.359Likely Benign-1.42Neutral0.992Probably Damaging0.989Probably Damaging5.30Benign0.25Tolerated3.824320.0-14.03
c.901G>AA301T
(3D Viewer)
Likely BenignC2Uncertain 56-33437806-G-A21.24e-6-3.448Likely Benign0.070Likely BenignLikely Benign0.150Likely Benign0.36Likely Benign0.2-0.33Likely Benign0.02Likely Benign0.03Likely Benign-0.25Neutral0.997Probably Damaging0.989Probably Damaging4.15Benign0.22Tolerated4.321410-2.530.03219.8-42.8-0.10.0-0.50.2UncertainThe methyl group of Ala301, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), points outward from the β hairpin loop, and its backbone atoms do not participate in the loop formation in the WT simulations. In the variant simulations, the hydroxyl group of the Thr301 side chain also mostly points outward; however, the guanidinium group of Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.1066C>TR356C
(3D Viewer)
Likely PathogenicC2Likely Benign 16-33437971-C-T53.10e-6-11.827Likely Pathogenic0.774Likely PathogenicLikely Benign0.312Likely Benign0.76Ambiguous0.01.19Ambiguous0.98Ambiguous0.84Ambiguous-7.12Deleterious1.000Probably Damaging0.990Probably Damaging1.67Pathogenic0.00Affected3.3922-4-37.0-53.05212.391.0-0.10.3-0.30.1XPotentially PathogenicArg356 is located in a loop that includes a short helical section and connects two anti-parallel β sheet strands (res. Gly341-Pro349, res. Thr359-Pro364). In the WT simulations, the guanidinium group of Arg356 alternately forms salt bridges with the carboxylate groups of the GAP domain residues, Glu446 and Glu698. Arg356 also forms hydrogen bonds with the hydroxyl group of the GAP domain residue Thr691 and interacts with Met409 at the C2-GAP interface.In the variant simulations, the Cys356 mutation fails to maintain any of the Arg356 interactions and only occasionally forms weak hydrogen bonds with nearby C2 domain residues (e.g., Gln407). Although no negative structural effects are observed during the simulations, Arg356 is located at the C2 and GAP domain interface, making the residue swap potentially detrimental to the tertiary structure assembly.
c.1285C>TR429W
(3D Viewer)
GAPConflicting 56-33438190-C-T654.03e-5-10.666Likely Pathogenic0.500AmbiguousLikely Benign0.282Likely Benign0.31Likely Benign0.1-0.13Likely Benign0.09Likely Benign0.52Ambiguous-3.19Deleterious1.000Probably Damaging0.990Probably Damaging3.41Benign0.03Affected3.38252-33.630.03252.345.50.00.00.20.1XPotentially PathogenicThe guanidinium group of Arg429, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or a H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, the indole ring of the Trp429 side chain cannot form ionic interactions with the acidic residues. Although it forms a H-bond with Ser471, the bonding is not as strong as that of arginine. The residue swap could affect the tertiary structure assembly during folding; however, no large-scale negative effects were seen during the simulations.
c.1730C>GA577G
(3D Viewer)
Likely BenignGAPBenign/Likely benign 26-33440782-C-G16.20e-7-5.717Likely Benign0.268Likely BenignLikely Benign0.443Likely Benign0.83Ambiguous0.01.02Ambiguous0.93Ambiguous0.86Ambiguous-1.84Neutral0.997Probably Damaging0.990Probably Damaging-1.31Pathogenic0.31Tolerated3.373410-2.2-14.03158.723.60.00.00.00.0XPotentially BenignAla577 is located near the end and outer surface of an α-helix (res. Arg563-Glu578), where its methyl group does not form any particular interactions in the WT simulations. The introduced residue, glycine, is known as an “α-helix breaker.” However, the residue swap caused only minor helix shortening in one of the replica simulations for the variant system. Regardless, the residue swap seems to be well tolerated based on the variant simulations.
c.2147G>AR716Q
(3D Viewer)
GAPConflicting 26-33441612-G-A42.48e-6-8.338Likely Pathogenic0.308Likely BenignLikely Benign0.210Likely Benign-0.01Likely Benign0.00.47Likely Benign0.23Likely Benign0.58Ambiguous-3.14Deleterious1.000Probably Damaging0.990Probably Damaging3.35Benign0.02Affected3.509111.0-28.06250.048.90.00.0-0.50.0XUncertainThe guanidinium group of Arg716, located on the outer surface of an α-helix (res. Leu714-Arg726), forms a salt bridge with the carboxylate group of Asp720. In the variant simulations, the carboxamide group of Gln716 also forms a hydrogen bond with the carboxylate group of Asp720, although this bond is weaker than the Arg716 salt bridge in the WT. Overall, no adverse effects on the protein structure are observed in the simulations. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.467T>GF156CLikely PathogenicUncertain 1-13.658Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.297Likely Benign-3.54Deleterious0.999Probably Damaging0.990Probably Damaging3.92Benign0.00Affected-4-2-0.3-44.04
c.76G>AG26RLikely BenignBenign 16-33423485-G-A31.86e-6-2.946Likely Benign0.678Likely PathogenicLikely Benign0.189Likely Benign-2.22Neutral0.994Probably Damaging0.990Probably Damaging3.87Benign0.00Affected4.321-3-2-4.199.14
c.1436G>AR479Q
(3D Viewer)
Likely BenignGAPUncertain 16-33438468-G-A74.34e-6-7.109In-Between0.259Likely BenignLikely Benign0.191Likely Benign0.54Ambiguous0.10.57Ambiguous0.56Ambiguous0.49Likely Benign-1.16Neutral1.000Probably Damaging0.991Probably Damaging3.42Benign0.31Tolerated3.3932111.0-28.06
c.1214G>AR405H
(3D Viewer)
Likely PathogenicC2Conflicting 26-33438119-G-A42.48e-6-9.081Likely Pathogenic0.706Likely PathogenicLikely Benign0.371Likely Benign2.79Destabilizing0.61.85Ambiguous2.32Destabilizing1.26Destabilizing-4.54Deleterious1.000Probably Damaging0.991Probably Damaging3.65Benign0.01Affected3.3828201.3-19.05214.0102.2-0.10.0-0.70.1XPotentially PathogenicThe guanidinium group of Arg405, located in an anti-parallel β sheet strand of the C2 domain (res. Pro398-Ile411), forms a salt bridge with the carboxylate group of the Glu446 side chain from an opposing α helix (res. Val441-Ser457) in the GAP domain. The positively charged Arg405 side chain also stacks with the aromatic ring of the Phe358 side chain from a loop preceding the β strand (res. Thr359-Thr366), which could assist in maintaining the anti-parallel strand arrangement.In the variant simulations, the imidazole ring of His405 does not stack with the aromatic ring of Phe358 nor form any lasting H-bonds with the loop residues. The imidazole ring of His405 (neutral and epsilon protonated in the simulations) is unable to form a salt bridge with Glu446, which could affect the tertiary structure assembly, although this is not apparent based on the variant simulations.
c.1424G>AR475Q
(3D Viewer)
Likely PathogenicGAPUncertain 26-33438456-G-A53.10e-6-12.087Likely Pathogenic0.721Likely PathogenicLikely Benign0.632Likely Pathogenic0.71Ambiguous0.10.12Likely Benign0.42Likely Benign0.82Ambiguous-3.65Deleterious1.000Probably Damaging0.991Probably Damaging-1.32Pathogenic0.01Affected3.3928111.0-28.06253.652.70.00.0-0.80.0XXXPotentially PathogenicIn the WT simulations, the guanidinium group of Arg475, located near the end of an α-helix (res. Ala461-Phe476), stacks with the phenyl ring of Phe476 and forms a salt bridge with Glu472. Additionally, Arg475 occasionally forms another salt bridge with the carboxylate group of Glu486 on the α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. Therefore, Arg475 potentially plays a key role in positioning the loop by interacting with Glu486, which is necessary for the positioning of the “arginine finger” (Arg485) and, ultimately, for RasGTPase activation. In the variant simulations, Asn475 forms a hydrogen bond with Arg479 on the proceeding α-α loop. The absence of Phe476/Arg475 stacking and the Arg475-Glu472 salt bridge weakens the integrity of the terminal end of the α-helix during the variant simulations. Lastly, the potential effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1811C>TS604L
(3D Viewer)
Likely PathogenicGAPUncertain 16-33440863-C-T63.72e-6-14.683Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.639Likely Pathogenic-0.94Ambiguous0.1-1.24Ambiguous-1.09Ambiguous-0.31Likely Benign-5.97Deleterious1.000Probably Damaging0.991Probably Damaging3.09Benign0.00Affected3.3735-3-24.626.08234.0-49.60.00.10.30.5XXPotentially PathogenicSer604 is located in a short turn between an α helix (res. Glu582-Met603) and a short α helical section (res. Ser606-Phe608). In the WT simulations, the hydroxyl side chain of Ser604 periodically hydrogen bonds with the backbone carbonyl groups of other α helix residues (e.g., Pro600, Met603). Serine weakens the α helix secondary structure, and thus, Ser604 along with Pro605 breaks the α helix, facilitating the turn in the WT structure.In contrast, in the variant simulations, Leu604 forms a few hydrophobic interactions (e.g., Leu607, Phe608). More importantly, the helix end is more stable than with Ser604 in the WT. The residue swap could have a more profound effect on the actual folding process, for example, by preventing the bending at the α helix end, than what the simulations suggest.Moreover, Ser604 directly hydrogen bonds with Ras residues Ser65 and Ala66 in the WT SynGAP-Ras complex. The hydrophobic leucine cannot maintain these interactions with Ras at the GAP-Ras interface. Thus, the effect of the residue swap on the complex formation with the GTPase cannot be fully explored in the solvent-only simulations.
c.2714G>AR905HLikely BenignUncertain 16-33443266-G-A84.96e-6-4.182Likely Benign0.457AmbiguousLikely Benign0.192Likely Benign-1.11Neutral1.000Probably Damaging0.991Probably Damaging2.59Benign0.09Tolerated3.775201.3-19.05
c.3487C>GH1163DUncertain 1-2.107Likely Benign0.949Likely PathogenicAmbiguous0.476Likely Benign-2.60Deleterious0.991Probably Damaging0.991Probably Damaging5.44Benign0.31Tolerated3.8831-1-0.3-22.05
c.3923G>AR1308HUncertain 16-33451797-G-A31.86e-6-3.586Likely Benign0.201Likely BenignLikely Benign0.319Likely Benign-3.12Deleterious0.998Probably Damaging0.991Probably Damaging2.33Pathogenic0.00Affected3.775201.3-19.05
c.3995C>TT1332MLikely Benign 16-33451869-C-T201.86e-5-4.107Likely Benign0.948Likely PathogenicAmbiguous0.252Likely Benign-3.63Deleterious1.000Probably Damaging0.991Probably Damaging2.95Benign0.00Affected3.775-1-12.630.09
c.773G>AR258H
(3D Viewer)
C2Benign/Likely benign 36-33437678-G-A106.20e-6-10.533Likely Pathogenic0.525AmbiguousLikely Benign0.830Likely Pathogenic1.60Ambiguous0.61.00Ambiguous1.30Ambiguous1.47Destabilizing-4.06Deleterious1.000Probably Damaging0.991Probably Damaging5.77Benign0.01Affected3.3915201.3-19.05212.581.80.10.0-0.50.2XPotentially PathogenicThe guanidinium group of Arg258, located at the end of an α-β loop connecting the PH domain to the C2 domain (res. Lys251-Arg258), forms hydrogen bonds with the carboxamide groups of Asn727 and Asn729 side chains, as well as with the backbone carbonyl groups of Ala724, Leu725, and Asn727 in the WT simulations. Although the imidazole group of His258 can act as a hydrogen bond donor/acceptor, the swapped residue is unable to maintain an equally well-coordinated hydrogen bond network for linking the C2 and GAP domains in the variant simulations.
c.1606T>GL536V
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.014Likely Pathogenic0.269Likely BenignLikely Benign0.586Likely Pathogenic1.25Ambiguous0.31.22Ambiguous1.24Ambiguous1.20Destabilizing-2.81Deleterious0.998Probably Damaging0.992Probably Damaging-1.34Pathogenic0.09Tolerated3.3734210.4-14.03204.726.40.20.0-0.20.2XPotentially BenignLeu536 is located on an α-helix (res. Ala533-Val560) at the membrane interface. The iso-butyl group of Leu536 interacts with nearby hydrophobic residues in the preceding loop (e.g., Val526, Pro528, Cys531). In the variant simulations, the iso-propyl side chain of Val536 forms similar hydrophobic interactions as Leu536 in the WT, causing no negative structural effects.
c.1349C>AA450E
(3D Viewer)
Likely PathogenicGAPUncertain 1-16.578Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.653Likely Pathogenic3.86Destabilizing0.25.23Destabilizing4.55Destabilizing1.59Destabilizing-4.67Deleterious0.999Probably Damaging0.992Probably Damaging3.38Benign0.07Tolerated3.37320-1-5.358.04240.1-82.60.00.00.70.0XXPotentially PathogenicThe methyl group of Ala450, located in an α helix (res. Asn440-Thr458), packs against hydrophobic residues in the inter-helix space (e.g., Leu692). In the variant simulations, the carboxylate group of the Glu450 side chain rotates outward, away from the hydrophobic niche, where it does not form any lasting salt bridges or H-bonds. Although the residue swap does not negatively affect the protein structure based on the simulations, it is possible that the introduction of the negatively charged residue adversely affects the folding process or tertiary assembly.
c.1393C>GL465V
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.893Likely Pathogenic0.838Likely PathogenicAmbiguous0.276Likely Benign2.46Destabilizing0.12.66Destabilizing2.56Destabilizing1.21Destabilizing-2.98Deleterious0.996Probably Damaging0.992Probably Damaging2.44Pathogenic0.10Tolerated3.3734210.4-14.03204.330.90.00.0-0.40.6XPotentially BenignThe iso-butyl side chain of Leu465, located in the middle of an α helix (res. Ala461–Phe476), packs with hydrophobic residues (e.g., Phe464, Met468, Tyr497, Ile494) in an inter-helix space formed with two other α helices (res. Ala461–Phe476 and res. Thr488-Gly502). In the variant simulations, the iso-propyl side chain of Val465 is equally sized and similarly hydrophobic as the original side chain of Leu465. Hence, the mutation does not exert any negative effects on the protein structure based on the variant simulations.
c.1873C>GL625VLikely PathogenicGAPUncertain 1-11.319Likely Pathogenic0.833Likely PathogenicAmbiguous0.480Likely Benign1.80Ambiguous0.71.69Ambiguous1.75Ambiguous1.42Destabilizing-2.96Deleterious0.998Probably Damaging0.992Probably Damaging3.07Benign0.01Affected210.4-14.03
c.1819C>GL607V
(3D Viewer)
Likely PathogenicGAPUncertain 26-33440871-C-G21.24e-6-11.190Likely Pathogenic0.637Likely PathogenicLikely Benign0.715Likely Pathogenic1.04Ambiguous0.21.36Ambiguous1.20Ambiguous0.90Ambiguous-2.99Deleterious0.985Probably Damaging0.992Probably Damaging-1.50Pathogenic0.01Affected3.3735210.4-14.03216.328.10.10.00.90.2XPotentially BenignLeu607 is located in a short helical region (res. Ser606-Phe608) within an α-α loop connecting two α helices (res. Glu582-Met603 and res. Glu617-Asn635). In the WT simulations, the iso-butyl side chain of Leu607 does not interact with any other residues, but it could potentially interact directly with Ras due to its location at the GAP domain.In the variant simulations, Val607, which has similar size and physicochemical properties to leucine, does not cause any negative effects on the protein structure. However, due to its location at the GAP-Ras interface, the residue swap could affect the complex formation with the GTPase, but this cannot be investigated using solvent-only simulations.
c.2608C>GL870VLikely BenignUncertain 1-4.123Likely Benign0.300Likely BenignLikely Benign0.111Likely Benign-1.19Neutral0.997Probably Damaging0.992Probably Damaging2.64Benign0.12Tolerated3.883210.4-14.03
c.2627C>TS876LUncertain 2-5.856Likely Benign0.489AmbiguousLikely Benign0.249Likely Benign-3.56Deleterious0.998Probably Damaging0.992Probably Damaging2.57Benign0.05Affected3.775-2-34.626.08
c.3020G>AS1007NLikely BenignBenign 1-5.113Likely Benign0.803Likely PathogenicAmbiguous0.075Likely Benign-1.54Neutral0.997Probably Damaging0.992Probably Damaging2.65Benign0.01Affected3.77511-2.727.03
c.3494C>TS1165LLikely BenignConflicting 2-2.984Likely Benign0.793Likely PathogenicAmbiguous0.166Likely Benign-2.01Neutral0.998Probably Damaging0.992Probably Damaging2.60Benign0.33Tolerated3.883-3-24.626.0810.1016/j.ajhg.2020.11.011
c.3557C>TS1186LCoiled-coilUncertain 16-33444592-C-T-4.829Likely Benign0.923Likely PathogenicAmbiguous0.177Likely Benign-2.58Deleterious0.998Probably Damaging0.992Probably Damaging2.65Benign0.04Affected3.824-3-24.626.08
c.3572G>AR1191QLikely BenignCoiled-coilUncertain 26-33444607-G-A95.58e-6-1.069Likely Benign0.943Likely PathogenicAmbiguous0.343Likely Benign-1.41Neutral0.998Probably Damaging0.992Probably Damaging2.68Benign0.08Tolerated3.824111.0-28.06
c.3731G>AS1244NLikely PathogenicCoiled-coilUncertain 1-9.008Likely Pathogenic0.751Likely PathogenicLikely Benign0.154Likely Benign-1.87Neutral0.997Probably Damaging0.992Probably Damaging2.10Pathogenic0.15Tolerated3.77511-2.727.03
c.930G>CE310D
(3D Viewer)
Likely PathogenicC2Likely Pathogenic1-11.218Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.666Likely Pathogenic1.87Ambiguous0.52.39Destabilizing2.13Destabilizing1.04Destabilizing-2.76Deleterious0.997Probably Damaging0.992Probably Damaging1.19Pathogenic0.02Affected3.3819320.0-14.03232.627.20.10.00.10.1XPotentially BenignThe carboxylate group of Glu310, located in an anti-parallel β sheet strand (res. Thr305-Asn315), is ideally positioned to interact with the hydroxyl and backbone amide groups of Thr295 on a twisted anti-parallel β strand. Because the carboxylate group can also interact with the GAP domain residues (e.g., Gln612, Tyr614), Glu310 potentially plays a key role in maintaining the tertiary assembly between the C2 and GAP domains. In the variant simulations, the carboxylate group of Asp310 can form the same interactions as glutamate; however, due to its one hydrocarbon shorter length, the connections are less stable or less optimal.
c.1402A>GM468V
(3D Viewer)
GAPUncertain 1-9.461Likely Pathogenic0.361AmbiguousLikely Benign0.570Likely Pathogenic2.69Destabilizing0.12.20Destabilizing2.45Destabilizing0.89Ambiguous-1.66Neutral0.998Probably Damaging0.993Probably Damaging-1.21Pathogenic0.08Tolerated3.3731122.3-32.06
c.1408A>GM470V
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.856Likely Pathogenic0.478AmbiguousLikely Benign0.770Likely Pathogenic2.73Destabilizing0.11.88Ambiguous2.31Destabilizing1.31Destabilizing-3.58Deleterious0.999Probably Damaging0.993Probably Damaging-1.20Pathogenic0.15Tolerated3.3734122.3-32.06
c.1540A>TI514F
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.383Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.601Likely Pathogenic2.35Destabilizing0.33.74Destabilizing3.05Destabilizing0.93Ambiguous-3.98Deleterious0.997Probably Damaging0.993Probably Damaging2.89Benign0.00Affected3.373501-1.734.02
c.1600T>CS534P
(3D Viewer)
Likely BenignGAPUncertain 16-33438843-T-C31.86e-6-5.056Likely Benign0.265Likely BenignLikely Benign0.203Likely Benign-0.40Likely Benign0.20.35Likely Benign-0.03Likely Benign0.47Likely Benign-3.81Deleterious0.993Probably Damaging0.993Probably Damaging3.32Benign0.05Affected3.3735-11-0.810.04
c.1354G>TV452F
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.769Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.511Likely Pathogenic9.21Destabilizing0.10.37Likely Benign4.79Destabilizing0.61Ambiguous-4.94Deleterious0.999Probably Damaging0.993Probably Damaging3.29Benign0.00Affected3.3734-1-1-1.448.04249.4-35.70.00.00.40.1XPotentially PathogenicThe iso-propyl side chain of Val452, located in the middle of an α helix (res. Val441-Ser457), packs against hydrophobic residues in the inter-helix space at the intersection of three α helices (e.g., Leu500, His453, Leu465). In the variant simulations, the larger side chain of Phe452 cannot pack against the opposing α helix (res. Leu489-Glu519) as efficiently as valine. Due to space restrictions, the phenol ring adjusts to make room by rotating slightly sideways in the inter-helix space. Besides this small and local shift, no large-scale effects on the protein structure are seen based on the simulations. However, the size difference between the swapped residues could affect the protein folding process.
c.3922C>TR1308CConflicting 26-33451796-C-T42.48e-6-4.994Likely Benign0.421AmbiguousLikely Benign0.352Likely Benign-4.89Deleterious0.999Probably Damaging0.993Probably Damaging2.31Pathogenic0.00Affected3.775-4-37.0-53.05
c.772C>TR258C
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437677-C-T16.20e-7-10.285Likely Pathogenic0.790Likely PathogenicAmbiguous0.771Likely Pathogenic1.17Ambiguous0.41.76Ambiguous1.47Ambiguous0.87Ambiguous-6.79Deleterious1.000Probably Damaging0.993Probably Damaging5.77Benign0.00Affected3.3915-3-47.0-53.05
c.775C>TR259W
(3D Viewer)
Likely PathogenicC2Uncertain 1-12.186Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.691Likely Pathogenic1.95Ambiguous0.80.51Ambiguous1.23Ambiguous0.51Ambiguous-7.35Deleterious1.000Probably Damaging0.993Probably Damaging5.76Benign0.00Affected3.39152-33.630.03254.040.00.20.20.20.4XXXPotentially PathogenicThe guanidinium group of Arg259, located at the beginning of an anti-parallel β sheet strand (res. Arg259-Arg272), forms salt bridges with the carboxylate groups of Asp684 at the end of an α helix (res. Ile683-Gln702, GAP domain) and Asp261 on the same β strand. The Arg259 side chain also frequently forms hydrogen bonds with the backbone carbonyl groups of Ser257, Asn256, and Asp255. In the variant simulations, the indole ring of the Trp259 side chain cannot form salt bridges or maintain hydrogen bonding with the carboxylate group of Asp684 or other nearby residues. Notably, the amino group of the Lys254 side chain maintains a salt bridge with Asp684 and Glu244 throughout the variant simulations, while it forms a cation-π bond with the indole ring of Trp259 in the variant. This salt bridge is not maintained in the WT simulations. Additionally, the partially or loosely α helical conformation of a lysine-containing loop (res. Lys251-Ser257), which extends to a nearby α helix (res. Met414-Asn426), could be stabilized due to the residue swap. Moreover, the bulky size of the Trp259 side chain requires nearby residues to adjust their positioning to accommodate the introduced residue, weakening the tertiary structure assembly between the C2, PH, and GAP domains. The residue swap potentially causes more severe effects during protein folding or for the SynGAP-membrane interaction than the solvent-only simulations imply.
c.1483G>AE495K
(3D Viewer)
Likely PathogenicGAPUncertain 1-11.478Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.869Likely Pathogenic0.15Likely Benign0.20.66Ambiguous0.41Likely Benign0.70Ambiguous-3.91Deleterious0.999Probably Damaging0.994Probably Damaging-1.29Pathogenic0.01Affected3.373510-0.4-0.94
c.1789T>CF597L
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.173Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.929Likely Pathogenic0.74Ambiguous0.12.12Destabilizing1.43Ambiguous1.20Destabilizing-5.97Deleterious0.999Probably Damaging0.994Probably Damaging-2.06Pathogenic0.13Tolerated201.0-34.02
c.2246G>AR749QLikely BenignLikely Benign 16-33441711-G-A42.48e-6-3.069Likely Benign0.212Likely BenignLikely Benign0.152Likely Benign-1.00Neutral0.999Probably Damaging0.994Probably Damaging2.64Benign0.03Affected4.322111.0-28.06
c.2474C>TS825LLikely PathogenicUncertain 16-33443026-C-T16.20e-7-4.987Likely Benign0.910Likely PathogenicAmbiguous0.249Likely Benign-4.30Deleterious0.999Probably Damaging0.994Probably Damaging1.94Pathogenic0.01Affected3.775-2-34.626.08
c.2089T>CW697R
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33441348-T-C16.20e-7-10.020Likely Pathogenic0.941Likely PathogenicAmbiguous0.401Likely Benign1.14Ambiguous0.11.18Ambiguous1.16Ambiguous1.25Destabilizing-9.50Deleterious1.000Probably Damaging0.994Probably Damaging3.45Benign0.02Affected3.46132-3-3.6-30.03254.4-41.20.00.0-0.70.0XPotentially BenignThe indole ring of Trp697, located on the outer surface of an α-helix (res. Leu685-Val699), is not involved in any long-lasting interactions in the WT simulations. In the variant simulations, the positively charged guanidinium side chain of Arg697 occasionally forms hydrogen bonds with nearby residues, such as Ser722 and Asn719. However, similar to Trp697 in the WT, Arg697 does not form any long-lasting interactions and thus does not induce any negative structural effects in the simulations.
c.3794G>CR1265TLikely PathogenicCoiled-coilLikely Pathogenic 1-10.129Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.529Likely Pathogenic-4.97Deleterious0.997Probably Damaging0.994Probably Damaging2.29Pathogenic0.00Affected3.775-1-13.8-55.08
c.3977C>AP1326QLikely BenignUncertain 16-33451851-C-A16.40e-7-5.422Likely Benign0.128Likely BenignLikely Benign0.138Likely Benign-0.86Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.775-10-1.931.01
c.3977C>GP1326RLikely BenignUncertain 1-5.097Likely Benign0.240Likely BenignLikely Benign0.133Likely Benign-0.82Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.7750-2-2.959.07
c.3977C>TP1326LLikely BenignUncertain 1-5.541Likely Benign0.115Likely BenignLikely Benign0.117Likely Benign-1.06Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.775-3-35.416.04
c.815G>AR272Q
(3D Viewer)
C2Uncertain 26-33437720-G-A148.67e-6-9.559Likely Pathogenic0.286Likely BenignLikely Benign0.321Likely Benign0.73Ambiguous0.10.15Likely Benign0.44Likely Benign1.00Destabilizing-1.81Neutral0.999Probably Damaging0.994Probably Damaging1.88Pathogenic0.03Affected3.3819111.0-28.06255.752.90.00.0-0.20.1XUncertainThe guanidinium group of Arg272, located at the end of an anti-parallel β sheet strand (res. Arg259-Arg272), is stably maintained in an upright and outward position via stacking with the indole ring of the Trp362 side chain in another β strand (res. Thr359-Pro364). In the WT simulations, Arg272 forms hydrogen bonds with the glycine-rich Ω loop residues (res. Val365-Pro398, e.g., Gly380) and creates a salt bridge with the carboxylate group of the Asp304 side chain.In the variant simulations, the carboxamide group of the Gln272 side chain does not stack with the indole ring of Trp362 as stably as the guanidinium group of Arg272 in the WT. Consequently, the Gln272 side chain is freer to interact with the loop residues than Arg272, potentially negatively affecting the dynamic SynGAP-membrane association. Additionally, Arg272 faces the RasGTPase interface, so the residue swap could impact the SynGAP-Ras complex formation and GTPase activation.
c.971G>AR324Q
(3D Viewer)
Likely BenignC2Uncertain 36-33437876-G-A31.86e-6-5.001Likely Benign0.173Likely BenignLikely Benign0.307Likely Benign0.56Ambiguous0.10.63Ambiguous0.60Ambiguous1.02Destabilizing-1.17Neutral0.999Probably Damaging0.994Probably Damaging1.92Pathogenic0.41Tolerated3.3922111.0-28.06
c.844T>AC282S
(3D Viewer)
Likely PathogenicC2Uncertain 1-11.846Likely Pathogenic0.958Likely PathogenicLikely Pathogenic0.460Likely Benign1.55Ambiguous0.11.23Ambiguous1.39Ambiguous1.62Destabilizing-9.19Deleterious0.997Probably Damaging0.994Probably Damaging1.64Pathogenic0.03Affected3.39180-1-3.3-16.06233.214.8-0.10.0-0.20.3XPotentially BenignThe thiol-containing side chain of Cys282, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), packs against multiple hydrophobic residues (e.g., Ile268, Leu284, Trp308, Leu327). In the variant simulations, the hydroxyl-containing side chain of Ser282 is more hydrophilic and, hence, not as favorable as Cys282 for this hydrophobic niche. Due to this polarity difference, the residue swap could potentially weaken the hydrophobic packing of the C2 domain during the folding process.Moreover, because the C2 domain interacts with the membrane, there could also be a negative effect on the stability of the SynGAP-membrane association. However, no large-scale structural changes were observed during the variant simulations. The hydroxyl group of Ser282 forms a hydrogen bond with the backbone carbonyl group of His326 in another β strand (res. Ala322-Arg329), which competes directly with the backbone amide group of Glu283 within the secondary structure element.
c.1622C>GA541G
(3D Viewer)
GAPUncertain 16-33438865-C-G21.24e-6-7.233In-Between0.341AmbiguousLikely Benign0.421Likely Benign0.67Ambiguous0.00.94Ambiguous0.81Ambiguous0.76Ambiguous-1.48Neutral0.999Probably Damaging0.995Probably Damaging-1.31Pathogenic0.57Tolerated3.373510-2.2-14.03170.123.60.00.00.00.0XPotentially PathogenicAla541 is located on the outer surface of an α-helix (res. Ala533-Val560). The methyl group of Ala541 is on the surface and does not form any interactions. Glycine, known as an “α-helix breaker,” weakens the integrity of the helix. Indeed, in the variant simulations, the hydrogen bond formation between Gly541 and the backbone carbonyl of Ala537 is disrupted.
c.1423C>TR475W
(3D Viewer)
Likely PathogenicGAPUncertain 16-33438455-C-T16.20e-7-13.235Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.725Likely Pathogenic1.44Ambiguous0.4-0.92Ambiguous0.26Likely Benign0.56Ambiguous-7.56Deleterious1.000Probably Damaging0.995Probably Damaging-1.45Pathogenic0.00Affected3.39282-33.630.03266.939.60.00.00.00.1XXXPotentially PathogenicIn the WT simulations, the guanidinium group of Arg475, located near the end of an α-helix (res. Ala461-Phe476), stacks with the phenyl ring of Phe476 and forms a salt bridge with Glu472. Additionally, Arg475 occasionally forms another salt bridge with the carboxylate group of Glu486 on the α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. Therefore, Arg475 potentially plays a key role in positioning the loop by interacting with Glu486, which is necessary for the positioning of the “arginine finger” (Arg485) and, ultimately, for RasGTPase activation.In the variant simulations, Trp475 moves and stacks with Arg479 on the proceeding α-α loop, disrupting the terminal end of the α-helix. Lastly, the potential effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1736G>AR579Q
(3D Viewer)
Likely PathogenicGAPUncertain 16-33440788-G-A181.12e-5-9.193Likely Pathogenic0.690Likely PathogenicLikely Benign0.673Likely Pathogenic0.65Ambiguous0.10.70Ambiguous0.68Ambiguous1.13Destabilizing-3.31Deleterious1.000Probably Damaging0.995Probably Damaging-1.34Pathogenic0.06Tolerated3.3734111.0-28.06

Found 757 rows. Show 200 rows per page. Page 3/4 |